PORTLAND, Ore., Oct. 6, 2020 /PRNewswire/ — Variant Investments, LLC announced that the Variant Alternative Income Fund observed its 3-year anniversary on September 30, 2020.  Over that period, the Fund has delivered annualized net returns of 7.87%, with relatively limited volatility or correlation to public market indices.   

Please find more performance information here.

“We are very proud of the performance of the Fund over these last three years” said JB Hayes, Variant Co-Founder and Principal.  “Our focus on less correlated market niches really proved its value during the recent COVID-19 stress period.  The team is excited as ever about our pipeline of investment opportunities”.     

The Fund also crossed the $500 million mark in assets under management (AUM) on August 14, 2020.  The steady pace of AUM growth owes to adoption of the strategy across a broad range of investors, particularly among Registered Investment Advisors (RIAs) seeking alternative

Read More

Here’s what you need to know:

Credit…Stefani Reynolds for The New York Times

The United States budget deficit hit a record $3 trillion for the 2020 fiscal year in August, the Treasury Department said on Friday, as the government’s economic rescue and falling tax receipts continued to put huge strain on the nation’s finances.

The extraordinary figures come as the Trump administration and Congress remain deadlocked in negotiations over additional stimulus measures, with Republicans wary of another big fiscal package and Democrats pushing for trillions of dollars in relief.

The budget deficit for the month of August was $200 billion. The coronavirus pandemic has slowed corporate and individual tax receipts, while government spending has surged, widening the gap between what the

Read More

The S&P and NASDAQ continued trekking through record territory to begin this week, assisted by some encouraging news on coronavirus treatment.

It’s also a big help that the market is simply in a fantastic mood right now with those two indices recovering all of the pandemic plunge, despite not having a new relief package and recently receiving a rather cautious outlook from the Fed.

The market can’t get enough of positive news on fighting the coronavirus, so it really appreciated that the FDA issued an emergency use authorization for convalescent plasma for hospitalized patients. It’s not a vaccine of course, but it will save lives.

There’s also talk of the White House fast-tracking an experimental vaccine out of the U.K.

Given such encouragement on the virus front, tech wasn’t the only space propping up the market. The recovery names did well too, such as airlines, casinos and cruise companies. In

Read More